Sundrug Co.,Ltd. (9989.T)
JPY 3932.0
(-0.13%)
JPY 3932.0
(-0.13%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 56.23 Billion JPY | 11.94% |
| 2022 | 49.51 Billion JPY | 11.85% |
| 2021 | 44.26 Billion JPY | -4.03% |
| 2020 | 46 Billion JPY | 2.8% |
| 2019 | 44.96 Billion JPY | 3.36% |
| 2018 | 43.47 Billion JPY | -1.21% |
| 2017 | 43.86 Billion JPY | 6.54% |
| 2016 | 41.71 Billion JPY | 4.0% |
| 2015 | 39.44 Billion JPY | 22.94% |
| 2014 | 32.15 Billion JPY | -4.83% |
| 2013 | 33.66 Billion JPY | 12.37% |
| 2012 | 30.34 Billion JPY | -44.85% |
| 2011 | 27.39 Billion JPY | 12.71% |
| 2010 | 23.09 Billion JPY | 22.55% |
| 2009 | 19.51 Billion JPY | 18.04% |
| 2008 | 17.28 Billion JPY | 8.67% |
| 2007 | 15.66 Billion JPY | 109.67% |
| 2006 | 14.75 Billion JPY | 4.6% |
| 2005 | 14.13 Billion JPY | 12.53% |
| 2004 | 12.63 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 14.7 Billion JPY | 85.13% |
| 2023 Q1 | 10.1 Billion JPY | 23.07% |
| 2023 Q3 | 12.83 Billion JPY | 18.19% |
| 2023 Q4 | 12.13 Billion JPY | -5.44% |
| 2023 FY | - JPY | 11.94% |
| 2023 Q2 | 10.85 Billion JPY | 7.4% |
| 2022 Q4 | 8.21 Billion JPY | -26.48% |
| 2022 FY | - JPY | 11.85% |
| 2022 Q1 | 9.17 Billion JPY | 35.83% |
| 2022 Q2 | 9.61 Billion JPY | 4.84% |
| 2022 Q3 | 11.17 Billion JPY | 16.22% |
| 2021 Q3 | 9.71 Billion JPY | 14.53% |
| 2021 Q4 | 6.75 Billion JPY | -30.52% |
| 2021 FY | - JPY | -4.03% |
| 2021 Q1 | 9.75 Billion JPY | 30.9% |
| 2021 Q2 | 8.48 Billion JPY | -13.04% |
| 2020 Q3 | 10.57 Billion JPY | 14.14% |
| 2020 Q1 | 10.84 Billion JPY | 21.19% |
| 2020 FY | - JPY | 2.8% |
| 2020 Q4 | 7.45 Billion JPY | -29.53% |
| 2020 Q2 | 9.26 Billion JPY | -14.54% |
| 2019 Q2 | 10.39 Billion JPY | 7.17% |
| 2019 Q4 | 8.94 Billion JPY | 10.04% |
| 2019 Q3 | 8.13 Billion JPY | -21.76% |
| 2019 FY | - JPY | 3.36% |
| 2019 Q1 | 9.69 Billion JPY | 15.44% |
| 2018 Q3 | 9.91 Billion JPY | 17.7% |
| 2018 FY | - JPY | -1.21% |
| 2018 Q2 | 8.42 Billion JPY | -7.03% |
| 2018 Q4 | 8.4 Billion JPY | -15.3% |
| 2018 Q1 | 9.06 Billion JPY | 3.8% |
| 2017 Q1 | 8.99 Billion JPY | 7.49% |
| 2017 FY | - JPY | 6.54% |
| 2017 Q2 | 8.83 Billion JPY | -1.82% |
| 2017 Q4 | 8.73 Billion JPY | -14.72% |
| 2017 Q3 | 10.23 Billion JPY | 15.91% |
| 2016 Q1 | 8.5 Billion JPY | 6.82% |
| 2016 Q3 | 9.71 Billion JPY | 17.29% |
| 2016 FY | - JPY | 4.0% |
| 2016 Q4 | 8.37 Billion JPY | -13.88% |
| 2016 Q2 | 8.28 Billion JPY | -2.55% |
| 2015 Q2 | 8.59 Billion JPY | 8.87% |
| 2015 Q1 | 7.89 Billion JPY | 10.67% |
| 2015 FY | - JPY | 22.94% |
| 2015 Q3 | 9.38 Billion JPY | 9.2% |
| 2015 Q4 | 7.96 Billion JPY | -15.15% |
| 2014 Q2 | 5.79 Billion JPY | 7.54% |
| 2014 FY | - JPY | -4.83% |
| 2014 Q3 | 8.2 Billion JPY | 41.71% |
| 2014 Q1 | 5.38 Billion JPY | -29.24% |
| 2014 Q4 | 7.13 Billion JPY | -13.1% |
| 2013 Q2 | 7.31 Billion JPY | 10.97% |
| 2013 Q3 | 7.27 Billion JPY | -0.55% |
| 2013 Q4 | 7.6 Billion JPY | 4.61% |
| 2013 FY | - JPY | 12.37% |
| 2013 Q1 | 6.59 Billion JPY | 3.42% |
| 2012 FY | - JPY | -44.85% |
| 2012 Q3 | 6.73 Billion JPY | 1.78% |
| 2012 Q4 | 6.37 Billion JPY | -5.35% |
| 2012 Q1 | 5.58 Billion JPY | -83.5% |
| 2012 Q2 | 6.61 Billion JPY | 18.48% |
| 2011 Q4 | 33.84 Billion JPY | 485.35% |
| 2011 Q1 | 5.3 Billion JPY | -83.2% |
| 2011 FY | - JPY | 12.71% |
| 2011 Q2 | 5.66 Billion JPY | 6.85% |
| 2011 Q3 | 5.78 Billion JPY | 2.07% |
| 2010 Q3 | 6.44 Billion JPY | 6.92% |
| 2010 FY | - JPY | 22.55% |
| 2010 Q2 | 6.02 Billion JPY | 15.3% |
| 2010 Q1 | 5.22 Billion JPY | -79.78% |
| 2010 Q4 | 31.55 Billion JPY | 389.64% |
| 2009 Q3 | 4.74 Billion JPY | -9.22% |
| 2009 Q1 | 4.34 Billion JPY | 0.0% |
| 2009 FY | - JPY | 18.04% |
| 2009 Q2 | 5.22 Billion JPY | 20.23% |
| 2009 Q4 | 25.85 Billion JPY | 444.72% |
| 2008 FY | - JPY | 8.67% |
| 2007 FY | - JPY | 109.67% |
| 2006 FY | - JPY | 4.6% |
| 2005 FY | - JPY | 12.53% |
| 2004 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| HEARTSEED INC | -1.44 Billion JPY | 3983.195% |
| Cawachi Limited | 11.85 Billion JPY | -374.511% |
| Pharmarise Holdings Corporation | 2.08 Billion JPY | -2596.021% |
| Qol Holdings Co., Ltd. | 14.21 Billion JPY | -295.743% |
| MatsukiyoCocokara & Co. | 98.01 Billion JPY | 42.624% |
| Welcia Holdings Co., Ltd. | 67.62 Billion JPY | 16.837% |
| Create SD Holdings Co., Ltd. | 24.34 Billion JPY | -130.98% |
| NIHON CHOUZAI Co.,Ltd. | 14.65 Billion JPY | -283.753% |
| COSMOS Pharmaceutical Corporation | 51.42 Billion JPY | -9.359% |
| Tsuruha Holdings Inc. | 67.2 Billion JPY | 16.318% |
| Ohki Healthcare Holdings Co.,Ltd. | 3.81 Billion JPY | -1373.768% |
| Satudora Holdings Co.,Ltd. | 2.71 Billion JPY | -1973.709% |
| Kusuri No Aoki Holdings Co., Ltd. | 30.64 Billion JPY | -83.542% |
| Medical System Network Co., Ltd. | 6.99 Billion JPY | -703.874% |
| Shinnihonseiyaku Co., Ltd. | 4.18 Billion JPY | -1242.861% |
| Sugi Holdings Co.,Ltd. | 50.74 Billion JPY | -10.829% |
| YAKUODO HOLDINGS Co., Ltd. | 8.16 Billion JPY | -588.95% |
| Astena Holdings Co., Ltd. | 4.17 Billion JPY | -1247.938% |
| Genky DrugStores Co., Ltd. | 14.47 Billion JPY | -288.552% |
| Ain Holdings Inc. | 31.22 Billion JPY | -80.126% |